Etanercept – Licensed indications

In the USA the FDA has licenced Enbrel for : *Moderate to Severe Rheumatoid Arthritis (RA) (Nov 1998) *Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) (1999) *Psoriatic Arthritis (2002) *Ankylosing Spondylitis (AS) (July 2003) *Moderate to Severe Plaque Psoriasis (April.

In the USA the FDA has licenced Enbrel for :

*Moderate to Severe Rheumatoid Arthritis (RA) (Nov 1998)

*Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) (1999)

*Psoriatic Arthritis (2002)

*Ankylosing Spondylitis (AS) (July 2003)

*Moderate to Severe Plaque Psoriasis (April 2004)


Adapted from the Wikipedia article Etanercept, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki








Related Articles

In the acute setting, indications for tracheotomy include such conditions as severe facial trauma, head and neck cancers, large congenital tumors of t...
PsoriasisBetamethasone is a corticosteroid used as a topical cream to relieve skin irritation, such as itching and flaking from eczema. Betamethasone dipropion...
Systemic Autoimmune DiseaseThe indication for kidney transplantation is end-stage renal disease (ESRD), regardless of the primary cause. This is defined as a drop in the glomeru...
Inflammatory bowel diseaseSome of the most common indications for colectomy are: * Colon cancer. * Diverticulitis and diverticular disease of the large intestine. * Trauma. * I...
Psoriatic ArthritisEtanercept (trade name Enbrel) is a drug that treats autoimmune diseases by interfering with the tumor necrosis factor (TNF, a part of the immune syst...